| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.0M | +28.1% |
| Cost of Revenue | $6.3M | +15.0% |
| Gross Profit | $2.6M | +75.9% |
| R&D Expense | $15.0M | +10.0% |
| SG&A Expense | $20.7M | +35.3% |
| Operating Income | -$49.6M | -48.1% |
| Pre-tax Income | -$48.7M | -52.5% |
| Income Tax | $63K | +6.8% |
| Net Income | -$48.8M | -52.4% |
| EPS (Basic) | -$0.76 | +0.0% |
| EPS (Diluted) | -$0.76 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.9M | -52.7% |
| Short-term Investments | $45.3M | +188.0% |
| Accounts Receivable | $2.2M | +37.9% |
| Inventory | $3.4M | +32.1% |
| Current Assets | $61.5M | +51.7% |
| Total Assets | $69.4M | +48.3% |
| Current Liabilities | $10.7M | +39.5% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.1M | -60.5% |
| Capital Expenditures | $1.7M | +18.5% |
| Investing Cash Flow | -$30.6M | -341.8% |
| Financing Cash Flow | $55.6M | +201.2% |
| Free Cash Flow | -$36.8M | -58.0% |
| $14.2M |
| +32.5% |
| Stockholders' Equity | $55.2M | +53.0% |